Because HA is naturally found in skin, it is often used in formulation of skin care products, such as topical creams or injectable dermal fillers. HA helps keep the skin hydrated, as well as fill out facial wrinkles and fine lines, and brings volume back to sunken or hollow areas of the face. Because crosslinked HA degrades much more slowly than free HA, HA-based fillers can remain in the face for several months, providing much longer lasting results than collagen-based fillers.
HA-based facial fillers are naturally reabsorbed by the body over a period of six months to a year, providing optimal wrinkle correction. Over time, the skin on the face goes through transitions in texture and firmness, so the ideal dermal filler will gradually diminish in volume over time, allowing the patient and dermatologist to re-apply the filler, accommodating changes in the patient’s skin.
Anika’s first HA-based dermal filler, ELEVESS™, is available in the EU, Canada and the U.S., through physicians trained in dermal filler injections. ELEVESS is packaged in units of 1 mL, a volume appropriate for filling of facial lines of medium depth, particularly nasolabial folds. ELEVESS, like other dermal fillers, is injected directly into the patient’s skin; however, the formulation of our product reduces injection pain through the addition of the anesthetic lidocaine.
Long-lasting, more natural effects, combined with ease of use and patient comfort are a result of the highest concentration of HA of any available dermal filler. ELEVESS is the first HA-based dermal filler in the U.S. to include lidocaine in its formulation, greatly increasing patient comfort during the injection procedure. Additional benefits of ELEVESS include a unique, patented HA crosslinker, an ergonomically designed syringe and unique extrusion properties that allow easy injection through a 30g needle.